Analyst Research

Report Title Price
Provider: GlobalData
Provider: Thomson Reuters Stock Report
Provider: Wright Reports
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sun Pharmaceutical Industries Ltd Ends Deal To Take Over Israeli Unit Taro Pharmaceutical Industries Ltd-Reuters

Saturday, 9 Feb 2013 11:04am EST 

Reuters reported that Sun Pharmaceutical Industries Ltd has ended its agreement to gain full control over its Israeli unit Taro Pharmaceutical Industries Ltd. Sun Pharma had last offered $39.50 per share, or about $571 million, for the one-third stake it did not already own in Taro, seemingly winning over the Israeli company's board following a long battle to gain full control of the U.S.-listed drugmaker. 

Company Quote

7.65 +0.95%
26 Dec 2014